Author

A. Cole Edwards

Icahn School of Medicine at Mount SinaiPrimary ORCID profile (0000-0001-9220-9642 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

A. Cole EdwardsiD3 papers · University of Pennsylvania

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Adolfo García‐SastreiD· 1 shared Alice Oliffson KamphorstiD· 1 shared Amir HorowitziD· 1 shared Anita RogiciD· 1 shared Ignacio MenaiD· 1 shared Mihaela SkobeiD· 1 shared Noelia DasilvaiD· 1 shared Rosa KarlićiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adolfo García‐SastreORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy

Rubén Fernández‐Rodríguez, Sara Cuadrado‐Castano, A. Cole Edwards, Anita Rogic, Yonina Bykov, Ignacio Mena, Noelia Dasilva, Alice Oliffson Kamphorst, Rosa Karlić, Amir Horowitz, Adolfo García‐Sastre, Mihaela Skobe

This study shows that VEGF-C promotes lymphangiogenesis in tumors, enhancing immune cell infiltration and enabling complete tumor eradication with viral immunotherapy.

bioRxiv · Aug 27, 2025 · PreprintCancer Biology